WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H574033
CAS#: 2250261-59-5
Description: F092 inhibitor, also called Prostaglandin D synthase (hematopoietic-type) inhibitor F092, is an inhibitor of hematopoietic-type prostaglandin D synthase (H-PGDS).
Hodoodo Cat#: H574033
Name: F092 inhibitor
CAS#: 2250261-59-5
Chemical Formula: C20H17N5O2
Exact Mass: 359.14
Molecular Weight: 359.390
Elemental Analysis: C, 66.84; H, 4.77; N, 19.49; O, 8.90
Synonym: Prostaglandin D synthase (hematopoietic-type) inhibitor F092; F092 inhibitor; F092; F-092; F 092;
IUPAC/Chemical Name: N-[4-(2-oxo-1-pyrrolidinyl)phenyl]-2-(2-pyridinyl)-5-pyrimidinecarboxamide
InChi Key: MYYXEGDPWAHVAZ-UHFFFAOYSA-N
InChi Code: InChI=1S/C20H17N5O2/c26-18-5-3-11-25(18)16-8-6-15(7-9-16)24-20(27)14-12-22-19(23-13-14)17-4-1-2-10-21-17/h1-2,4,6-10,12-13H,3,5,11H2,(H,24,27)
SMILES Code: O=C(NC1=CC=C(N2CCCC2=O)C=C1)C(C=N3)=CN=C3C4=CC=CC=N4
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 359.39 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1. Takaya, D., Inaka, K., Omura, A., et al. Characterization of crystal water molecules in a high-affinity inhibitor and hematopoietic prostaglandin D synthase complex by interaction energy studies. Bioor. Med. Chem. 26(16), 4726-4734 (2018).
